英文别名 |
Prostacyclin sodium salt;Sodium (5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dien-1-oate;Epoprostenol Sodium;(5-Z)-9-DEOXY-6,9ALPHA-EPOXY-PGF1ALPHA,SODIUM SALT;Epoprostenol;PGI2·Na (Prostaglandin I2·Na, Prostacyclin);Prostacyclin Sodium;Prostaglandin I2 (sodium salt);Flolan;PG12-NA;PGI2;PGI2 sodium;PGI2,SODIUM SALT;PGI2-NA;Prostaglandin 12;PROSTAGLANDIN I2;Sodium PGI2;(5Z,9α,11α,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt;Prostaglandin I2 sodium salt;EPOPROSTENOL SODIUM [USAN];Tox21_112431;Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate;AKOS024457370;Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate;Epoprostenolsodium;CHEMBL962;EPOPROSTENOL SODIUM (USP-RS);Q27259818;EX-A7849M;35121-78-9 , Epoprostenol;EPOPROSTENOL SODIUM [VANDF];HMS1361K18;(5Z,13E,8R,9S,11R,12R,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt;Sodium(Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate;DTXSID3046617;DTXCID1026617;Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer;SODIUM (Z)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((E)-(3S)-3-HYDROXY-1-OCTENYL)-2H-CYCLOPENTA(B)FURAN-.DELTA.(SUP 2,.DELTA.)-VALERATE;Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (5Z,9alpha,11alpha,13E,15S)-;EPOPROSTENOL SODIUM [WHO-DD];PROSTACYCLIN SODIUM SALT [MI];NS00074283;sodium (Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-enyl)hexahydro-2H-cyclopenta[b]furan-2-ylidene)pentanoate;Sodium prostacyclin;Prostaglandin X sodium;UNII-4K04IQ1OF4;U-53,217A;EPOPROSTENOL SODIUM (MART.);CAS-61849-14-7;61849-14-7;4UA76;LMHIPJMTZHDKEW-XQYLJSSYSA-M;EPOPROSTENOL SODIUM [MART.];Monosodium (Z)-(3aR,4R,5R,6aS)-3,3a,4,5,6,6a-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta2,dvalerate;Epoprostenol sodium [USAN:BAN];U 53,217A;4K04IQ1OF4;U-53217A;NCGC00167427-01;PROSTAGLANDIN I2 Na;PROSTA-5,13-DIEN-1-OIC ACID, 6,9-EPOXY-11,15-DIHYDROXY-, SODIUM SALT, (5Z,9.ALPHA.,11.ALPHA.,13E,15S)-;SCHEMBL41344;EINECS 263-273-7;EPOPROSTENOL SODIUM [USP-RS];HMS3648L14;EPOPROSTENOL SODIUM [JAN];BML1-F10;Cyclo-Prostin;35121-78-9;EPOPROSTENOL SODIUM [ORANGE BOOK];sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate;(5Z,9?,11?,13E,15S)-6,9-epoxy-11,15-Dihydroxy-prosta-5,13-dien-1-oic Acid Sodium Salt; Epoprostenol Sodium; Flolan; |